MarketInOut Stock Screener Log In | Sign Up
 

Biofrontera AG

XETRA • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 07/03/2026 17:43
Biofrontera AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization14.16 mln
Float1.40 mln
Earnings Date06/03/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.5
Borderline

Relative Strength

12 / 100
Significantly lagging

Debt / Equity

0.07
Debt-free

ROE

-14.98
Negative

Dividend Yield

0.00%
No dividend

Business Description

Biofrontera AG is a German pharmaceutical company founded in 1997 and based in Leverkusen, focused on developing and selling skincare treatments across Europe, the United States, and beyond. Its main products include Ameluz gel and specialized light devices used by doctors to treat precancerous skin conditions and certain forms of skin cancer. The company also offers Belixos, a gentle cosmetic line designed for sensitive or irritated skin.

Key Fundamentals

EPS-1.09
ROE-14.98
RPS2.25
ROIC-7.47
ROA-10.76
EBITDA, mln-0.51
EV / EBITDA-18.95
EV / EBIT-10.27
Revenue, mln13.63
EV / Revenue0.71

Financial Strength

Altman Z-Score-5.36
Piotroski F-Score 5 / 9
Beneish M-Score-2.5

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.86% 15 / 100   
1 Month -11.49% 5 / 100   
2 Months -6.85% 10 / 100   
6 Months -12.17% 12 / 100   
1 Year -1.7% 21 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us